// App-Quantinova.ai

: Second Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma after a Previous Autograft: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Researchers

Presenter

  • Carmen Martinez

Principal Investigators

  • Ariane Boumendil

  • Joanna Romejko-Jarosinska

  • Achilles Anagnostopoulos

  • Edgar Faber

  • Xavier Poire

  • Ibrahim Yakoub-Agha

  • Saad Akhtar

  • Gunhan Gurman

  • Vincenzo Pavone

  • Kazimierz Halaburda

  • Aida Botelho Sousa

  • Herv Ghesquieres

  • Herv Finel

  • Irma Khvedelidze

  • Silvia Montoto

  • Anna Sureda

Medical Centers

  • Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, IDIBAPS, Josep Carreras Research Institute, Hospital Clinic, Barcelona, Spain

  • EBMT Lymphoma Working Party, Paris, France

  • The M.Sklodowska-Curie Memorial Cancer Center and Institute, Warsaw, Poland

  • Hematology Department/ BMT unit, G.Papanicolaou General Hospital, Thessaloniki, Greece

  • Department of Hemato-Oncology,University Hospital Olomouc and Faculty of Medicine and Dentistr

  • Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

  • CHU de Lille, LIRIC, INSERM U995, Université de Lille, France, Lille, France

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

  • Ankara Ufuk University,Faculty of Medicine, Ankara, Turkey

  • Azienda C. Panico, Tricase, ITA

  • Institute of Hematology and Transfusion Medicine, Warsaw, Poland

  • Hospital dos Capuchos, Lisboa, Portugal, Lisboa, Portugal

  • Hospices Civils de Lyon, Universite Claude Bernard, Centre Hospitalier Lyon-Sud, Pierre Benite, France

  • EBMT Lymphoma Working Party, Paris, France

  • EBMT Paris Office, Hospital Saint Antoine, Paris, France,

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Clinical Hematology Department, Institut Catala d'Oncologia-Hospitalet, Barcelona, Spain

Locations

  • Spain

  • France

  • Poland

  • Greece

  • Czech Republic

  • Belgium

  • Saudi Arabia

  • Portugal

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Adcetris

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved